Nasal delivery of thermostable and broadly neutralizing antibodies protects mice against SARS-CoV-2 infection  

作　　者：Wenhui Fan Shanshan Sun Ning Zhang Yuan Zhanq Pengtao Jiao Jian Wang George F.Gao Wenjun Liur Yuhai Bi Limin Yang 

机构地区：[1]CAS Key Laboratory of Pathogenic Microbiology and Immunology,Institute of Microbiology,Center for Influenza Research and Early-warning(CASCIRE),CAS-TWAS Center of Excellence for Emerging Infectious Diseases(CEEID),Chinese Academy of Sciences,Beijing 100101,China [2]Tianjin Speerise Challenge Biotechnology Co.,Ltd,Tianjin 300380,China [3]University of Chinese Academy of Sciences,Beijing 101409,China

出　　处：《Signal Transduction and Targeted Therapy》2022年第3期628-631,共4页信号转导与靶向治疗（英文）

基　　金：This study was supported by National Key Technologies Research and Development Program grants 2018YFC1200500 and 2018YFC1200600 to L.Y.and 2021YFC2300900 to Y.B.,Strategic Priority Research Program of Chinese Academy of Sciences XDB29010000 to W.L.and XDB29010102 to Y.B.,National Natural Science Foundation of China(NSFC)(32041010);NSFC Outstanding Young Scholars(31822055);Youth Innovation Promotion Association of CAS(2017122)to Y.B.

摘　　要：Dear Editor,The ongoing SARS-CoV-2 pandemic has lasted for 2 years,causing a severe global impact on social development.With widespread vaccinations,the number of new infections has dropped significantly,but with the emergence of diverse novel variants of concern(VOCs)and variants of interest(VOIs),there has been a second or third epidemic wave in many countries.

关 键 词：HAS dropped development. 

分 类 号：R563.1[医药卫生—呼吸系统]